Medidata Collaborates with MSK Cancer Center

Article

Medidata announces a collaboration with New York’s Memorial Sloan Kettering Cancer Center on a pilot study to expand the use of mHealth technology in oncology treatment.

Medidata announces a collaboration with New York’s Memorial Sloan Kettering Cancer Center on a pilot study to expand the use of mHealth technology in treatment for multiple myeloma. The companies will assess the viability of wearable sensors and mobile technology to evaluate patient quality of life during treatment.

Read the full release here

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.